Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Gastric Cancer. 2021 Apr 30;24(5):1076–1088. doi: 10.1007/s10120-021-01193-6

Figure 5. EBV gene expression and cell proliferation is decreased in EBV-positive GC treated in vivo.

Figure 5.

A. RT-PCR showing expression of EBNA1, EBNA2, LMP1, EBER1, EBER2, and BART Ex5 in SNU719 xenografts. B. RT-PCR showing expression of EBNA1, EBNA2, LMP1, EBER1, EBER2, and BART Ex5 in YCCEL1 xenografts. C. EBV viral loads in SNU719 and YCCEL1 tumor material from animals treated with VK-1727 or vehicle (Student T test; * p < 0.05, **p<0.01) D. Ki67 expression (mean fluorescence intensity as measured by flow cytometry).